Mycenax Biotech Inc. announced a private placement of up to 50,000,000 common shares on March 13, 2024. The transaction will include participation from returning investors Center Laboratories, Inc, JCR Pharmaceuticals Co., Ltd. and new investors Nien Hsing International Investment Co., Ltd., Jason Technology Co., Ltd., China Investment and Development Co., LTD., Pei-Jiun Chen, Chun-Hong Chen, Yoh Ito, En-Tzn Liu, Chia-Ling Lin, Yi-Hsin Lee, Wei-I Chou, Chin-Hao Liang and Li-Ju Yeh. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
43.85 TWD | -4.67% | -1.46% | +22.83% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
797 JPY | +0.50% | +2.05% | 632M | ||
43.85 TWD | -4.67% | -1.46% | 277M | ||
42.95 TWD | -0.92% | +2.26% | 903M | ||
1st Jan change | Capi. | |
---|---|---|
+22.83% | 277M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- 4726 Stock
- News Mycenax Biotech Inc.
- Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd